发明名称 Stabilized liquid and lyophilized adamts13 formulations
摘要 <p>598839 Disclosed is a stabilized formulation of ADAMTS 13 for lyophilization, comprising: (a) 0.05 mg/ml to 10.0 mg/ml ADAMTS13; (b) less than 100 mM of a pharmaceutically acceptable salt; (c) 0.5 mM to 20 mM calcium; (d) a sugar and/or sugar alcohol; (e) a nonionic surfactant; and (f) a buffering agent for maintaining a pH between 6.0 and 8.0.</p>
申请公布号 NZ598839(A) 申请公布日期 2014.03.28
申请号 NZ20100598839 申请日期 2010.09.21
申请人 BAXTER INTERNATIONAL INC.;BAXTER HEALTHCARE S.A. 发明人 SCHWARZ HANS-PETER;MATTHIESSEN H. PETER;TURECEK PETER L.
分类号 A61K9/00;A61K9/10;A61K38/43;A61K38/48 主分类号 A61K9/00
代理机构 代理人
主权项
地址